NCT03937713View on ClinicalTrials.gov

Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD

PHASE4CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

March 30, 2025

Conditions
Complex Insomnia
Interventions
DRUG

eszopiclone

Eszopiclone is a nonbenzodiazepine benzodiazepine receptor agonists, effective for both sleep onset insomnia and sleep maintenance insomnia

BEHAVIORAL

Brief behavioral therapy for insomnia

BBTI is based on the core principles that are fundamental to other empirically-supported behavioral treatments of insomnia delivered over four consecutive weeks.

Trial Locations (1)

14215-1129

VA Western New York Healthcare System, Buffalo, NY, Buffalo

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03937713 - Effectiveness of Combining Behavioral and Pharmacologic Therapy for Complex Insomnia in Veterans With PTSD | Biotech Hunter | Biotech Hunter